- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Nausea, diarrhea, and edema are common side effects during treatment with crizotinib. Scientific management helps improve the quality of life a...
To ensure efficacy and safety, the administration method, dosage adjustment, and management of missed doses of Crizotinib should follow the fol...
During the use of avatranib, special attention should be paid to the risk of thrombosis, hepatotoxicity, and drug interactions to ensure medica...
Avatrombopag can promote platelet production, but the medication risk is significantly increased in specific populations. The following is an e...
Proper use of Avatrombopag is the foundation for ensuring therapeutic efficacy. The following provides a concise guide on the administration me...
Afaripopa may cause side effects such as headache, fatigue, and nausea while increasing platelet count. Mastering scientific coping methods can...
The correct way of taking Axitinib directly affects its efficacy and safety. Mastering the timing of medication, principles of dosage adjustmen...
Axitinib is a targeted drug for lung cancer, but it needs to be discontinued or used with caution in some populations due to safety risks. The ...
Osimertinib is an oral third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). 1. Management of interstitial...
Osimertinib is an oral third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). 1. Diarrhea management Mil...
